AC Followed by Pertuzumab/Trastuzumab/Docetaxel Regimen

**Semantic type:** Therapeutic or Preventive Procedure

**Definition:** A regimen consisting of cyclophosphamide and doxorubicin followed by pertuzumab, trastuzumab, and docetaxel, used as a neoadjuvant or adjuvant treatment for HER-2/neu-positive breast cancer.

**Synonyms:** - AC Followed by Docetaxel + Pertuzumab + Trastuzumab - AC Followed by Docetaxel + Trastuzumab + Pertuzumab - AC Followed by Pertuzumab + Trastuzumab + Docetaxel - AC Followed by Pertuzumab-Trastuzumab-Docetaxel Regimen - AC-Pertuzumab + Trastuzumab + Docetaxel - AC-THP (Docetaxel) - AC-THP (Docetaxel) (trastuzumab-anns) - AC-THP (Docetaxel) (trastuzumab-dkst) - AC-THP (Docetaxel) (trastuzumab-dttb) - AC-THP (Docetaxel) (trastuzumab-herw) - AC-THP (Docetaxel) (trastuzumab-pkrb) - AC-THP (Docetaxel) (trastuzumab-qyyp) - AC-THP (Docetaxel) (trastuzumab-strf) - AC-THP (Docetaxel) (trastuzumab-zerc) - Doxorubicin/Cyclophosphamide Followed by Pertuzumab + Trastuzumab + Docetaxel - Doxorubicin/Cyclophosphamide Followed by Pertuzumab/Trastuzumab/Docetaxel